Drug · DIN 02275066
TROSEC
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 18, 2025; first marketed April 4, 2006.
- Drug Identification Number (DIN)
- 02275066
- Company (DIN owner)
- Sunovion Pharmaceuticals Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Trospium G04BD09
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TROSPIUM CHLORIDE | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 30, 2011: NOC 12670New Drug Submission (NDS) · Manufacturer Name Change
- November 13, 2009: NOC 10783New Drug Submission (NDS) · Manufacturer name change
- January 10, 2006: NOC 7677New Drug Submission (NDS)